Who Should Not Receive Adjuvant Chemotherapy? International Databases
Author:
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology,General Medicine
Link
http://academic.oup.com/jncimono/article-pdf/2001/30/103/9840892/103.pdf
Reference14 articles.
1. Tamoxifen for early breast cancer: an overview of the randomised trials
2. Polychemotherapy for early breast cancer: an overview of the randomised trials
3. Where next with stem-cell-supported high-dose therapy for breast cancer?
4. The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in premenopausal women.
5. Five-Hundred Life-Saving Interventions and Their Cost-Effectiveness
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Calibration of the E3SM Land Model Using Surrogate-Based Global Optimization;Journal of Advances in Modeling Earth Systems;2018-06
2. Pathologic diagnosis of breast cancer patients: evolution of the traditional clinical-pathologic paradigm toward “precision” cancer therapy;Biotechnic & Histochemistry;2017-03-20
3. A retrospective analysis of breast cancer subtype based on ER/PR and HER2 status in Ghanaian patients at the Korle Bu Teaching Hospital, Ghana;BMC Clinical Pathology;2015-07-09
4. Pathologic diagnosis, immunohistochemistry, multigene assays and breast cancer treatment: progress toward “precision” cancer therapy;Biotechnic & Histochemistry;2014-12
5. Invasive Breast Carcinoma;Pathobiology of Human Disease;2014
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3